Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
about
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Disease extent at secondary cy ...... ecologic Oncology Group study.
@ast
Disease extent at secondary cy ...... ecologic Oncology Group study.
@en
type
label
Disease extent at secondary cy ...... ecologic Oncology Group study.
@ast
Disease extent at secondary cy ...... ecologic Oncology Group study.
@en
prefLabel
Disease extent at secondary cy ...... ecologic Oncology Group study.
@ast
Disease extent at secondary cy ...... ecologic Oncology Group study.
@en
P2093
P2860
P1433
P1476
Disease extent at secondary cy ...... ecologic Oncology Group study.
@en
P2093
Angeles Alvarez-Secord
David P Warshal
Frederick B Stehman
James J Java
Joshua P Kesterson
Larry J Copeland
Mark A Morgan
Parviz Hanjani
Peter G Rose
Robert T Morris
P2860
P304
P356
10.1016/J.YGYNO.2016.09.005
P407
P577
2016-09-27T00:00:00Z